A Magnetic Resonance Imaging Study and Arthroscopic Biopsy Substudy in Subjects With Active Rheumatoid Arthritis Receiving VX-509, an Oral JAK3 Inhibitor
Clinical trial NCT01754935 · COMPLETED
Trial details
- NCT number
- NCT01754935
- Sponsor
- Vertex Pharmaceuticals Incorporated
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-01-01
- Primary completion
- 2014-01-01
- Enrollment
- 43
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.